Meets ISO 10993 and/or USP Class VI biocompatibility requirement. Eastar™ Copolyester MN211, Natural contains a mold release for improved ejection. It is a brilliantly clear polymer with good impact strength, chemical resistance, dimensional stability, and low shrinkage rates. The slower rate of crystallization of this material makes it excellent for use in hot runner systems with valve or thermal gates.
This product has been GREENGUARD INDOOR AIR QUALITY CERTIFIED
Eastman Medical Disclaimer
The GREENGUARD INDOOR AIR QUALITY CERTIFIED Mark is a registered certification mark used under license through the GREENGUARD Environmental Institute (GEI). GEI is an industry-independent, non-profit organization that oversees the GREENGUARD Certification Program. The GREENGUARD Certification Program is an industry independent, third-party testing program for low-emitting products and materials for indoor environments. For more information about GEI and to obtain printable certificates for Eastman™ Copolyesters, visit www.greenguard.org. Choose Eastman Chemical Company under the Manufacturer category and click search to display a list of our products.
It is the responsibility of the medical device manufacturer ("Manufacturer") to determine the suitability of all component parts and raw materials, including any Eastman product, used in its final product in order to ensure safety and compliance with requirements of the United States Food and Drug Administration (FDA) or other international regulatory agencies.
Eastman Chemical Company products have not been designed for nor are they promoted for end uses that would be categorized by either the United States FDA or by the International Standards Organization (ISO) as implant devices. Eastman products are not intended for use in the following applications: (1) in any bodily implant applications for greater than 30 days, based on FDA-Modified ISO-10993, Part 1 “Biological Evaluation of Medical Devices” tests (including any cosmetic, reconstructive or reproductive implant applications); (2) in any cardiac prosthetic device application, regardless of the length of time involved, including, without limitation, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass assisted devices, or (3) as any critical component in any medical device that supports or sustains human life.
Eastman Chemical Company products offered for the medical market have met selected FDA-Modified ISO-10993, Part 1 “Biological Evaluation of Medical Devices” tests with human tissue contact time of 30 days or less. The tests include: cytotoxicity, sensitization, irritation or intracutaneous reactivity, systemic toxicity (acute), subchronic toxicity (sub-acute), implantation, hemocompatibility. The Manufacturer is responsible for the biological evaluation of the finished medical device.
The suitability of an Eastman Product in a given end-use environment is dependent upon various conditions including, without limitation, chemical compatibility, temperature, part design, sterilization method, residual stresses, and external loads. It is the responsibility of the Manufacturer to evaluate its final product under actual end-use requirements and to adequately advise and warn purchasers and users thereof.
Properties reported here are based on limited testing. Eastman makes no representation that the material in any particular shipment will conform exactly to the values given.